Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

White hairs often regrow in alopecia areata patches.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Interleukin-6 may play a role in causing alopecia areata.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

CD2 might be a new treatment target for patchy alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Upadacitinib may cause hair loss.